Articles

Researchers compare fasting BG, HbA1c and 2-hour plasma glucose test.

Trials find intensive control reduced cardiovascular events in high-risk, diagnosed patients.

Excessive weight gain due to intensive therapy can lead to increased cardiovascular risk factors.

Post-hoc analysis of the breakthrough EMPA-REG Outcome trial demonstrated reduction in composite cardiovascular outcomes that can be seen with empagliflozin therapy.

Study shows that good periodontal health is necessary to achieve a favorable glycemic status.

Both patients with diabetes and health care professionals expect wider adoption of continuous glucose management systems in the future for patients with type 2 as well as type 1, and agree that cost is a key factor in patient choices

Risk of diabetes diagnosis higher in those who lost weight after age 25, but study finds result statistically insignificant.

Men and women with type 2 have different risk for obesity-related cancer when compared with general population.

Protecting the heart and helping to reduce mortality, study takes closer look at beta-adrenoceptor inhibition in diabetes.

Only 3.1% Americans engage in activities to prevent a diabetes diagnosis.